
Health Catalyst (HCAT) Stock
Cloud-based healthcare analytics platform for health systems. Here's the price, business snapshot, and what's worth knowing about Health Catalyst in November 2026.
Health Catalyst Inc (HCAT) is a healthcare data and analytics company that builds cloud-based platforms to help providers measure and improve clinical and financial outcomes. Its software combines data warehousing, analytics, and machine learning to support population health, care management and operational performance across hospitals and health systems. With a market capitalisation near $224m, HCAT is a relatively small, growth-oriented company that can be more volatile than larger peers. Revenue depends on adoption by health systems, recurring subscription contracts, and professional services. Investors should note competitive pressure from larger healthcare IT vendors, the pace of hospital digital transformation, and reimbursement or regulatory changes that affect customers’ budgets. This summary is educational, not personalised advice — values can rise and fall and returns are not guaranteed. Always check recent financials, management commentary and suitability for your objectives before considering any investment.
Why You’ll Want to Watch This Stock
Data-driven healthcare
Platform analytics and machine learning can help hospitals improve outcomes and efficiency, though adoption cycles and competition can affect growth.
Health system focus
Customers are predominantly hospitals and health systems, so sector spending and regulation influence demand; performance can vary with policy changes.
Small-cap dynamics
With a modest market capitalisation, HCAT can offer growth potential but also greater share-price volatility and liquidity risk.